ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 32967 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 32967; 2) Community: the network communities that were significantly associated with the response to NSC 32967; 3) Molecule: the relationships between components within communities and NSC 32967; 4) MDR: the compounds that were significantly associated with the NSC 32967.

NSC Compound Enrichment Correlation
NSC 740602 Null 0.0410413740044188 0.14843034
NSC 754328 Null 0.0410413740044188 -0.099088105
NSC 757949 (1R,2E,6R,10E,11aS,13S,14aR)-6-(2-(benzyloxy)ethyl)-1,13-dihydroxy-6,7,8,9,12,13,14,14a-octahydro-1H-cyclopenta[f][1]oxacyclotridecin-4(11aH)-one 0.0410413740044188 -0.11016877
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.0410413740044188 0.016373062
NSC 79563 1,3-bis(4-chlorobenzyl)-2-(phenanthren-9-yl)hexahydropyrimidine 0.0410413740044188 -0.14560744
NSC 88054 Null 0.0410413740044188 0.149908
NSC 10438 Azoresorcin 0.0423559437159349 -0.050890389
NSC 123111 Mitomycin derivative T 53 0.0423559437159349 0.15877814
NSC 127753 s-Triazine, 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(p-phenethylphenyl)-, monohydrochloride 0.0423559437159349 0.37012063
NSC 145669 4(1H)-Quinazolinone, 2,3-dihydro-2-(1-naphthalenyl)- (9CI) 0.0423559437159349 -0.1592835
Total:43  Current:38    [First] [Prev] [Next] [Last]